The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUniphar Regulatory News (UPR)

Share Price Information for Uniphar (UPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 224.00
Bid: 220.00
Ask: 228.00
Change: 0.00 (0.00%)
Spread: 8.00 (3.636%)
Open: 224.00
High: 224.00
Low: 223.00
Prev. Close: 224.00
UPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Durbin Acquisition

1 Aug 2019 07:00

RNS Number : 4600H
Uniphar PLC
01 August 2019
 

Uniphar plc

 

Completion of Durbin acquisition

 

 

Dublin, London | 1 August 2019: Uniphar plc (the "Group") today announces the successful completion of the acquisition of Durbin plc and Durbin Inc (together "Durbin"), a specialist provider of pharmaceuticals with offices in the UK and the US supplying over 160 countries.

 

Durbin will be integrated into Uniphar's Product Access division, providing the Group with the opportunity to become a leading player in the provision of On-Demand and Exclusive Access services on a global basis. Durbin has approximately 45 years' experience in shipping unlicensed and hard-to-find medicines and has built up significant global capability in managing access programmes for pharmaceutical manufacturers.

 

The Group's Product Access business will now comprise more than 170 employees, supplying more than 5 million units to more than 160 countries on an annual basis and will manage access programmes for 36 global manufacturers, from offices in Ireland, the UK and the US.

 

The acquisition of Durbin was financed out of the proceeds of the placing completed alongside the listing of the Group's shares on 17 July 2019.

 

 

Commenting on today's announcement,

Ger Rabbette, CEO of Uniphar said:

 

"We are delighted to welcome our new colleagues from Durbin to the Uniphar Group. This acquisition is a key strategic milestone in expanding Uniphar's global footprint and is an important step towards achieving our ambition of becoming a global leader in the Product Access space. Post the integration of Durbin, we believe that Uniphar will offer a compelling proposition to manufacturers seeking a commercial partner with global reach and scalable digital capabilities."

 

 

Leslie Morgan, CEO of Durbin said:

 

"We are delighted to be joining the Uniphar Group. Durbin has been a sourcing partner for Uniphar since 2011 and in that period, we have built a strong relationship with the management team. Uniphar's e-Commerce platform and Patient Management System are highly complementary to our capabilities and were a key attraction for us in bringing the businesses together. Combining Durbin's global sourcing and distribution platform as well as its regulatory and compliance expertise with Uniphar's digital capabilities will greatly enhance the enlarged Group's global ambitions within its Product Access division."

 

 

--- ENDS ---

 

For further details contact:

 

Uniphar

 

Brian O'Shaughnessy

Director of Investor Relations and Corporate Development

 

+353 (0) 1 428 7777

 

 

investor.relations@Uniphar.ie

 

 

Davy

(Joint Broker, Nominated Adviser and Euronext

Growth Adviser)

 

Fergal Meegan

Barry Murphy

Tom Tynan

 

 

+353 (0) 1 679 6363

RBC Capital Markets (Joint Broker)

Darrell Uden

Jonathan Hardy

Thomas Debrosse

 

 

+44 (0) 20 7653 4000

Q4 PR

(Public Relations Adviser to Uniphar)

 

Iarla Mongey

 

 

+353 (0) 1 475 1444

or

+353 87 235 6461

 

About Uniphar plc

 

Headquartered in Dublin, Ireland, Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access, and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK, the Benelux and now the US following the acquisition of Durbin.

 

In Commercial & Clinical, the Group provides sales, marketing and distribution solutions to pharmaceutical and medical devices manufacturers on an outsourced basis.

 

In Product Access, the Group is growing two distinct service offerings: 1) sourcing and supplying unlicensed medicines to meet the needs of pharmacy customers (On-Demand Access); and 2) managing the release of speciality medicines for pharmaceutical manufacturers to specifically approved patient populations (Exclusive Access).

 

Supply Chain & Retail is an Irish only business for the Group, with Uniphar being an established market leader in Ireland with c.50% of the wholesale market servicing retail pharmacy, supported by a network of 235 owned and franchised pharmacies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQSDEFWFFUSEEW
Date   Source Headline
9th May 20242:30 pmRNSAGM Results
9th May 20247:00 amRNSAGM Statement
26th Apr 20241:48 pmRNSHolding(s) in Company
15th Apr 20249:00 amRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSNotice of AGM & Annual Report
27th Feb 20247:00 amRNS2023 Preliminary Results
6th Feb 202410:30 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20247:00 amRNSDirectorate Change
24th Nov 202311:20 amRNSHolding(s) in Company
9th Oct 202311:00 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20233:33 pmRNSHolding(s) in Company
19th Sep 20239:29 amRNSHolding(s) in Company
14th Sep 20233:00 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNS2023 Interim Results
4th Sep 20237:00 amRNSHolding(s) in Company
1st Aug 20232:45 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
14th Jun 20235:00 pmRNSHolding(s) in Company
11th May 20233:32 pmRNSAGM Results
11th May 20237:00 amRNSAGM Statement
3rd May 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSNotice of AGM & Annual Report & Dividend Update
3rd Mar 20237:00 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNS2022 Preliminary Results
3rd Feb 20237:00 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSCompletion of McCauley Acquisition
31st Jan 20237:00 amRNSFull Year Trading Update and Notice of Results
25th Jan 20237:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSNavi acquisition not cleared by CCPC
8th Dec 20224:06 pmRNSHolding(s) in Company
2nd Dec 20227:00 amRNSNew Share Option Plan
21st Nov 20227:00 amRNSAcquisition of BModesto Group
4th Oct 20227:00 amRNSAcquisition of healthcare agency Inspired Health
19th Sep 20227:00 amRNSAcquisition of McCauley Pharmacy Group
14th Sep 20229:08 amRNSDirector/PDMR Shareholding
30th Aug 20227:00 amRNS2022 Interim Results
26th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
11th May 20224:16 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
7th Apr 20227:00 amRNSNotice of AGM & Annual Report
3rd Mar 20227:31 amRNSDirector/PDMR Shareholding
3rd Mar 20227:29 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20227:00 amRNS2021 Preliminary Results
21st Feb 20228:00 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSFull Year Trading Update & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.